Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma
Conditions
- Lymphoma
- Small Intestine Cancer
Interventions
- DRUG: vorinostat
- OTHER: Correlative studies
Sponsor
Ohio State University Comprehensive Cancer Center
Collaborators